Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Eton Pharmaceuticals, Inc. Common Stock
IPO Date: November 13, 2018
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Cap: $384.56M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.16 | 2.77%
Avg Daily Range (30 D): $0.44 | 3.32%
Avg Daily Range (90 D): $0.48 | 3.41%
Institutional Daily Volume
Avg Daily Volume: .18M
Avg Daily Volume (30 D): .22M
Avg Daily Volume (90 D): .24M
Trade Size
Avg Trade Size (Sh.): 141
Avg Trade Size (Sh.) (30 D): 68
Avg Trade Size (Sh.) (90 D): 68
Institutional Trades
Total Inst.Trades: 14
Avg Inst. Trade: $1.51M
Avg Inst. Trade (30 D): $.81M
Avg Inst. Trade (90 D): $.75M
Avg Inst. Trade Volume: .23M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.27M
Avg Closing Trade (30 D): $.81M
Avg Closing Trade (90 D): $.81M
Avg Closing Volume: 471.97K
       
News
May 9, 2024 @ 8:01 PM
Eton Pharmaceuticals Reports First Quarter 2024 Fi...
Source: Eton Pharmaceuticals
May 1, 2024 @ 8:05 PM
Eton Pharmaceuticals to Present at the Citizens JM...
Source: Eton Pharmaceuticals
Apr 30, 2024 @ 11:00 AM
Eton Pharmaceuticals Announces Submission to FDA o...
Source: Eton Pharmaceuticals
Apr 29, 2024 @ 8:30 PM
Eton Pharmaceuticals to Report First Quarter 2024 ...
Source: Eton Pharmaceuticals
Mar 22, 2024 @ 6:00 AM
Eton Pharmaceuticals Announces Acquisition of PKU...
Source: Eton Pharmaceuticals
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.15 $-.03 $-.15
Diluted EPS
Revenue $ 39.01M $ 11.65M $ 39.01M
Gross Profit $ 23.41M $ 6.48M $ 23.41M
Net Income / Loss $ -3.82M $ -.6M $ -3.82M
Operating Income / Loss $ -2.6M $ .63M $ -2.6M
Cost of Revenue $ 15.6M $ 5.17M $ 15.6M
Net Cash Flow $ -6.45M $ -5.33M $ -6.45M
PE Ratio